AnaptysBio Inc (ANAB.OQ)
ANAB.OQ on NASDAQ Stock Exchange Global Select Market
40.31USD
23 Aug 2019
40.31USD
23 Aug 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$40.31
$40.31
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
101,315
101,315
52-wk High
$110.00
$110.00
52-wk Low
$39.91
$39.91
About
AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro,... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $725.82 |
| Shares Outstanding(Mil.): | 20.34 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ANAB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.38 | 32.67 |
| EPS (TTM): | -1.06 | -- | -- |
| ROI: | -23.31 | 8.95 | 14.48 |
| ROE: | -48.33 | 10.09 | 15.78 |
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.✕
Estimates